<bill session="116" type="h" number="1425" updated="2020-12-28T14:39:52Z">
  <state datetime="2020-06-29T17:18:42-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2020-06-29T17:18:42-04:00"/>
  </status>
  <introduced datetime="2019-02-28"/>
  <titles>
    <title type="short" as="introduced">State Health Care Premium Reduction Act</title>
    <title type="short" as="reported to house">State Health Care Premium Reduction Act</title>
    <title type="short" as="passed house">Patient Protection and Affordable Care Enhancement Act</title>
    <title type="display">Patient Protection and Affordable Care Enhancement Act</title>
    <title type="official" as="introduced">To amend the Patient Protection and Affordable Care Act to provide for a Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market.</title>
  </titles>
  <sponsor bioguide_id="C001119"/>
  <cosponsors>
    <cosponsor bioguide_id="A000376" joined="2019-03-25"/>
    <cosponsor bioguide_id="B001300" joined="2019-05-30"/>
    <cosponsor bioguide_id="B001287" joined="2019-03-25"/>
    <cosponsor bioguide_id="B001303" joined="2019-03-25"/>
    <cosponsor bioguide_id="B001308" joined="2019-04-02"/>
    <cosponsor bioguide_id="B001285" joined="2019-03-12"/>
    <cosponsor bioguide_id="B001286" joined="2019-03-25"/>
    <cosponsor bioguide_id="C001112" joined="2019-03-07"/>
    <cosponsor bioguide_id="C001097" joined="2019-06-10"/>
    <cosponsor bioguide_id="C001055" joined="2019-04-02"/>
    <cosponsor bioguide_id="C001123" joined="2019-03-25"/>
    <cosponsor bioguide_id="C001067" joined="2019-04-02"/>
    <cosponsor bioguide_id="C001078" joined="2020-01-24"/>
    <cosponsor bioguide_id="C001059" joined="2019-03-26"/>
    <cosponsor bioguide_id="D000629" joined="2019-09-09"/>
    <cosponsor bioguide_id="D000624" joined="2019-03-26"/>
    <cosponsor bioguide_id="E000215" joined="2019-03-26"/>
    <cosponsor bioguide_id="F000467" joined="2019-03-26"/>
    <cosponsor bioguide_id="F000449" joined="2019-10-16"/>
    <cosponsor bioguide_id="H001064" joined="2019-03-11"/>
    <cosponsor bioguide_id="H001087" joined="2019-03-25"/>
    <cosponsor bioguide_id="H001047" joined="2019-03-18"/>
    <cosponsor bioguide_id="K000385" joined="2019-05-30"/>
    <cosponsor bioguide_id="K000379" joined="2019-03-26"/>
    <cosponsor bioguide_id="K000381" joined="2019-04-29"/>
    <cosponsor bioguide_id="K000368" joined="2019-11-18"/>
    <cosponsor bioguide_id="K000382" joined="2019-03-05"/>
    <cosponsor bioguide_id="L000560" joined="2019-03-26"/>
    <cosponsor bioguide_id="L000590" joined="2019-03-25"/>
    <cosponsor bioguide_id="L000563" joined="2019-03-07"/>
    <cosponsor bioguide_id="L000397" joined="2019-07-02"/>
    <cosponsor bioguide_id="L000570" joined="2019-03-25"/>
    <cosponsor bioguide_id="L000591" joined="2019-09-18"/>
    <cosponsor bioguide_id="M001163" joined="2019-03-27"/>
    <cosponsor bioguide_id="M001209" joined="2019-04-25"/>
    <cosponsor bioguide_id="M001143" joined="2019-04-08"/>
    <cosponsor bioguide_id="M001160" joined="2019-04-25"/>
    <cosponsor bioguide_id="M001207" joined="2019-04-29"/>
    <cosponsor bioguide_id="N000191" joined="2019-04-08"/>
    <cosponsor bioguide_id="P000034" joined="2019-03-26"/>
    <cosponsor bioguide_id="P000608" joined="2019-02-28"/>
    <cosponsor bioguide_id="P000616" joined="2019-03-27"/>
    <cosponsor bioguide_id="R000606" joined="2019-06-20"/>
    <cosponsor bioguide_id="R000602" joined="2019-11-19"/>
    <cosponsor bioguide_id="R000613" joined="2019-03-25"/>
    <cosponsor bioguide_id="R000616" joined="2019-03-25"/>
    <cosponsor bioguide_id="R000599" joined="2019-03-26"/>
    <cosponsor bioguide_id="R000515" joined="2019-03-26"/>
    <cosponsor bioguide_id="S001145" joined="2019-03-12"/>
    <cosponsor bioguide_id="S001150" joined="2019-03-26"/>
    <cosponsor bioguide_id="S001180" joined="2019-03-05"/>
    <cosponsor bioguide_id="S001216" joined="2019-03-25"/>
    <cosponsor bioguide_id="S001209" joined="2019-03-27"/>
    <cosponsor bioguide_id="S001175" joined="2020-01-24"/>
    <cosponsor bioguide_id="S001215" joined="2019-04-29"/>
    <cosponsor bioguide_id="T000469" joined="2019-05-30"/>
    <cosponsor bioguide_id="T000483" joined="2019-03-25"/>
    <cosponsor bioguide_id="U000040" joined="2019-03-04"/>
    <cosponsor bioguide_id="V000133" joined="2019-03-28"/>
    <cosponsor bioguide_id="W000800" joined="2019-06-10"/>
    <cosponsor bioguide_id="W000825" joined="2019-11-22"/>
  </cosponsors>
  <actions>
    <action datetime="2019-02-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-02-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-03-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-03-27">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2019-03-27">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 13 .</text>
    </action>
    <action datetime="2019-04-03">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2019-04-04" state="REPORTED">
      <text>Ordered to be Reported (Amended) by the Yeas and Nays: 30 - 22.</text>
    </calendar>
    <action datetime="2020-03-09">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-414.</text>
    </action>
    <calendar datetime="2020-03-09" calendar="Union" number="334">
      <text>Placed on the Union Calendar, Calendar No. 334.</text>
    </calendar>
    <action datetime="2020-06-24T19:02:39-04:00">
      <text>Rules Committee Resolution H. Res. 1017 Reported to House. Rule provides for consideration of H.R. 1425, H.R. 5332, H.R. 7120, H.R. 7301 and H.J. Res. 90. The resolution provides that the provisions of section 125(c) of the Uruguay Round Agreements Act shall not apply during the remainder of the 116th Congress and the resolution amends H.Res. 967, agreed to on May 15, 2020.</text>
    </action>
    <action datetime="2020-06-29T10:11:44-04:00">
      <text>Considered under the provisions of rule H. Res. 1017.</text>
      <reference ref="CR H2599-2644" label="consideration"/>
    </action>
    <action datetime="2020-06-29T10:11:49-04:00">
      <text>Rule provides for consideration of H.R. 1425, H.R. 5332, H.R. 7120, H.R. 7301 and H.J. Res. 90. The resolution provides that the provisions of section 125(c) of the Uruguay Round Agreements Act shall not apply during the remainder of the 116th Congress and the resolution amends H.Res. 967, agreed to on May 15, 2020.</text>
    </action>
    <action datetime="2020-06-29T10:13:11-04:00">
      <text>DEBATE - The House proceeded with three hours of debate on H.R. 1425.</text>
    </action>
    <action datetime="2020-06-29T13:59:46-04:00">
      <text>The previous question was ordered pursuant to the rule.</text>
    </action>
    <action datetime="2020-06-29T14:00:44-04:00">
      <text>Mr. Walden moved to recommit with instructions to the Committee on Energy and Commerce.</text>
      <reference ref="CR H2642-2643" label="text"/>
    </action>
    <action datetime="2020-06-29T14:00:56-04:00">
      <text>Floor summary: DEBATE - The House proceeded with 10 minutes of debate on the Walden motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to prevent the bill from taking effect unless the Secretary of Health and Human Services certifies that no provision of the bill would adversely affect research related to any drug intended to treat or prevent the virus that causes COVID-19.</text>
    </action>
    <action datetime="2020-06-29T14:08:54-04:00">
      <text>The previous question on the motion to recommit with instructions was ordered without objection.</text>
    </action>
    <action datetime="2020-06-29T14:09:28-04:00">
      <text>POSTPONED PROCEEDINGS - At the conclusion of debate on the motion to recommit with instructions, the Chair put the question on the motion and by voice vote, announced that the noes had prevailed. Mr. Walden demanded the yeas and nays and the Chair postponed further consideration on the motion to recommit until a time to be announced.</text>
    </action>
    <action datetime="2020-06-29T15:55:36-04:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H2664-2665" label="consideration"/>
    </action>
    <action datetime="2020-06-29T16:39:10-04:00">
      <text>On motion to recommit with instructions Failed by the Yeas and Nays: 187 - 223 (Roll no. 123).</text>
    </action>
    <vote how="roll" type="vote" roll="124" datetime="2020-06-29T17:18:42-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On passage Passed by the Yeas and Nays: 234 - 179 (Roll no. 124).</text>
      <reference ref="CR H2599-2614" label="text"/>
    </vote>
    <action datetime="2020-06-29T17:18:53-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2020-06-30">
      <text>Received in the Senate.</text>
    </action>
    <action datetime="2020-08-13">
      <text>Read the first time. Placed on Senate Legislative Calendar under Read the First Time.</text>
    </action>
    <calendar datetime="2020-09-08" calendar="Senate Legislative" under="General Orders" number="523">
      <text>Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 523.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="hr" session="116" relation="unknown" number="1017"/>
    <bill type="h" session="116" relation="unknown" number="1884"/>
    <bill type="h" session="116" relation="unknown" number="6136"/>
    <bill type="h" session="116" relation="unknown" number="6151"/>
    <bill type="h" session="116" relation="unknown" number="1879"/>
    <bill type="h" session="116" relation="unknown" number="6130"/>
    <bill type="h" session="116" relation="unknown" number="6149"/>
    <bill type="s" session="116" relation="unknown" number="1905"/>
    <bill type="h" session="116" relation="unknown" number="986"/>
    <bill type="h" session="116" relation="unknown" number="987"/>
    <bill type="h" session="116" relation="unknown" number="1385"/>
    <bill type="h" session="116" relation="unknown" number="1386"/>
    <bill type="h" session="116" relation="unknown" number="1870"/>
    <bill type="h" session="116" relation="unknown" number="4821"/>
    <bill type="s" session="116" relation="unknown" number="1400"/>
    <bill type="s" session="116" relation="unknown" number="2218"/>
    <bill type="h" session="116" relation="unknown" number="584"/>
    <bill type="h" session="116" relation="unknown" number="5291"/>
    <bill type="h" session="116" relation="unknown" number="6135"/>
    <bill type="s" session="116" relation="unknown" number="455"/>
    <bill type="s" session="116" relation="unknown" number="585"/>
    <bill type="s" session="116" relation="unknown" number="4521"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Appropriations"/>
    <term name="Government trust funds"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health programs administration and funding"/>
    <term name="State and local finance"/>
  </subjects>
  <amendments>
    <amendment number="h819"/>
  </amendments>
  <summary date="2020-03-09T13:35:53Z" status="Reported to House">State Health Care Premium Reduction Act

This bill establishes and provides funding for the Improve Health Insurance Affordability Fund. States must use allocated funds to (1) issue reinsurance payments to health insurers (i.e., reimbursements to protect insurers against exceedingly high claims) for individual health insurance coverage, or (2) provide other assistance to reduce out-of-pocket costs (e.g., copayments, coinsurance, and deductibles) for qualified health plans offered in the individual market through an exchange.

Reinsurance payments using such funds may not be applied to (1) grandfathered health plans in place on March 23, 2010, (2) non-grandfathered transitional plans meeting specified requirements identified by the Centers for Medicare &amp; Medicaid Services (CMS), or (3) student health insurance plans provided by institutions of higher education.

The bill appropriates $10 billion per year for the fund, which the CMS must distribute to states in accordance with a specified methodology based on the estimated amount of reinsurance payments for individuals in a state during the given year, subject to specified deductions. Additionally, states must submit applications explaining how they will use such funds. In the event that a state does not submit an application, the bill directs the CMS to allocate the calculated funding amount to reinsurance programs in that state.</summary>
  <committee-reports>
    <report>H. Rept. 116-414</report>
  </committee-reports>
</bill>
